The company is benefiting from a rebound in demand for nonurgent surgeries among older adults, who deferred those procedures during the Covid pandemic.
Spotify reported first quarter earnings before the bell on Tuesday. Here's
Gilead (GILD) delivered earnings and revenue surprises of 11.41% and 5.59%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Both platform revenue and devices revenue saw a year-over-year increase of
Investing.com - General Electric (NYSE: GE ) reported first quarter EPS of
United Parcel Service Inc. reported profit higher than analysts’ estimates as the courier’s headcount management and restructuring of its delivery routes began to bear fruit.
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its annual forecast on robust sales of its medical devices, including glucose-monitoring products. Sales of Abbott's medical devices have been strengthened in recent quarters due to a resurgence in the demand for joint replacements as well as other surgeries delayed during the COVID-19 pandemic. Industry bellwether and rival Johnson & Johnson said on Tuesday it continues to expect...
(Bloomberg) -- Charles Schwab Corp.’s first-quarter net revenue topped estimates as the retail brokerage tries to put 2023’s turbulence behind it, even as the firm’s net new assets plunged from a year earlier.Most Read from BloombergIsrael Versus Iran — What All-Out War Could Look LikeApple Faces Worst iPhone Slump Since Covid as Rivals RiseSingapore PM Lee to Hand Reins to Wong After Two DecadesTexas Warns of Possible Power Emergency Next WeekIran’s Attack on Israel Sparks Race to Avert a...
DETROIT — Sales of Ford Motor 's trucks and other commercial vehicles led
TSMC is the world's largest producer of advanced processors and counts
Lower volatility in foreign exchange markets also hurt profits. "What we see is really strong underlying underpinnings for the U.S. economy," CEO Robin Vince said, echoing the sentiments of other executives in the finance industry. He warned, however, that geopolitical tensions, uncertainty around the trajectory of interest rates and the United States fiscal deficit could have a destabilizing impact.
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.